INDEX PHARM. AB AK B Aktie - Unternehmensdaten & Kurse - SE0008966295 | MoneyPeak

INDEX PHARM. AB AK B

Share · SE0008966295 · A2ATYC (XSTO)

No Price

n/a

Share Float & Liquidity

Free Float 5,74 %

Shares Float 378,94 M

Shares Outstanding 6,61 B

Company Profile for INDEX PHARM. AB AK B Share

InDex Pharmaceuticals Holding AB (publ), a pharmaceutical development company, develops pharmaceutical products for patients with ulcerative colitis. The company's lead drug candidate is Cobitolimod, which is in phase III clinical development for the treatment of patients with moderate to severe ulcerative colitis. It also develops a portfolio of other DNA based immunomodulatory sequences in preclinical stage for the treatment of various immunological diseases. The company was founded in 2000 and is headquartered in Solna, Sweden.

Get up to date insights from finAgent about INDEX PHARM. AB AK B

Company Data

Name INDEX PHARM. AB AK B

Company InDex Pharmaceuticals Holding AB (publ)

Website https://www.indexpharma.com

Primary Exchange

NASDAQ STOCKHOLM AB

WKN A2ATYC

ISIN SE0008966295

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Jenny Sundqvist

Market Capitalization 4 Mrd.

Country Sweden

Currency SEK

Employees 0,0 T

Address Berzelius vAeg 13, 171 65 Solna

IPO Date 2016-10-11

Ticker Symbols

Name	Symbol
NASDAQ STOCKHOLM AB	INDEX.ST
Frankfurt	1NP.F

More Shares

Investors who hold INDEX PHARM. AB AK B also have the following shares in their portfolio:

Black Mountain Acquisition Corp. Share

JON + JON 2038 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2025